Cargando…
Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients
Circulating tumor DNA (ctDNA) offers new opportunities for noninvasive cancer management. Detecting ctDNA in plasma is challenging because it constitutes only a minor fraction of the total cell-free DNA (cfDNA). Pre-analytical factors affect cfDNA levels contributed from leukocyte lysis, hence the a...
Autores principales: | Risberg, Bente, Tsui, Dana W.Y., Biggs, Heather, Ruiz-Valdepenas Martin de Almagro, Andrea, Dawson, Sarah-Jane, Hodgkin, Charlotte, Jones, Linda, Parkinson, Christine, Piskorz, Anna, Marass, Francesco, Chandrananda, Dineika, Moore, Elizabeth, Morris, James, Plagnol, Vincent, Rosenfeld, Nitzan, Caldas, Carlos, Brenton, James D., Gale, Davina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Investigative Pathology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197164/ https://www.ncbi.nlm.nih.gov/pubmed/30165204 http://dx.doi.org/10.1016/j.jmoldx.2018.07.005 |
Ejemplares similares
-
Refined characterization of circulating tumor DNA through biological feature integration
por: Markus, Havell, et al.
Publicado: (2022) -
Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
por: Mouliere, Florent, et al.
Publicado: (2018) -
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer
por: Tsui, Dana Wai Yi, et al.
Publicado: (2018) -
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
por: Parkinson, Christine A., et al.
Publicado: (2016) -
Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma
por: Köbel, Martin, et al.
Publicado: (2016)